BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29017461)

  • 1. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry.
    Barbanti M; Baan J; Spence MS; Iacovelli F; Martinelli GL; Saia F; Bortone AS; van der Kley F; Muir DF; Densem CG; Vis M; van Mourik MS; Seilerova L; Lüske CM; Bramlage P; Tamburino C
    BMC Cardiovasc Disord; 2017 Oct; 17(1):259. PubMed ID: 29017461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation.
    Spence MS; Baan J; Iacovelli F; Martinelli GL; Muir DF; Saia F; Bortone AS; Densem CG; Owens CG; van der Kley F; Vis M; van Mourik MS; Costa G; Sykorova L; Lüske CM; Deutsch C; Kurucova J; Thoenes M; Bramlage P; Tamburino C; Barbanti M
    J Am Heart Assoc; 2020 Aug; 9(15):e016990. PubMed ID: 32715844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balloon expandable transcatheter aortic valve implantation via the transfemoral route with or without pre-dilation of the aortic valve - rationale and design of a multicentre registry (EASE-IT TF).
    Butter C; Bramlage P; Rudolph T; Jacobshagen C; Rothe J; Treede H; Kerber S; Frank D; Seilerova L; Schymik G
    BMC Cardiovasc Disord; 2016 Nov; 16(1):223. PubMed ID: 27846807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early discharge after transfemoral transcatheter aortic valve implantation.
    Barbanti M; Capranzano P; Ohno Y; Attizzani GF; Gulino S; Immè S; Cannata S; Aruta P; Bottari V; Patanè M; Tamburino C; Di Stefano D; Deste W; Giannazzo D; Gargiulo G; Caruso G; Sgroi C; Todaro D; di Simone E; Capodanno D; Tamburino C
    Heart; 2015 Sep; 101(18):1485-90. PubMed ID: 26076940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
    Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
    Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER).
    Salizzoni S; D'Onofrio A; Agrifoglio M; Colombo A; Chieffo A; Cioni M; Besola L; Regesta T; Rapetto F; Tarantini G; Napodano M; Gabbieri D; Saia F; Tamburino C; Ribichini F; Cugola D; Aiello M; Sanna F; Iadanza A; Pompei E; Stefàno P; Cappai A; Minati A; Cassese M; Martinelli GL; Agostinelli A; Fiorilli R; Casilli F; Reale M; Bedogni F; Petronio AS; Mozzillo RA; Bonmassari R; Briguori C; Liso A; Sardella G; Bruschi G; Fiorina C; Filippini C; Moretti C; D'Amico M; La Torre M; Conrotto F; Di Bartolomeo R; Gerosa G; Rinaldi M;
    Eur J Cardiothorac Surg; 2016 Dec; 50(6):1139-1148. PubMed ID: 27406375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trial.
    Durand E; Le Breton H; Lefevre T; Gilard M; Himbert D; Alcazar MU; Bettinger N; Auffret V; Didier R; Chevalier B; Béziau DM; Iung B; Eltchaninoff H
    Arch Cardiovasc Dis; 2020; 113(6-7):391-400. PubMed ID: 32418883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial.
    Barbanti M; van Mourik MS; Spence MS; Iacovelli F; Martinelli GL; Muir DF; Saia F; Bortone AS; Densem CG; van der Kley F; Bramlage P; Vis M; Tamburino C
    EuroIntervention; 2019 Jun; 15(2):147-154. PubMed ID: 30777842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Analysis of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation.
    Serletis-Bizios A; Durand E; Cellier G; Tron C; Bauer F; Glinel B; Dacher JN; Cribier A; Eltchaninoff H
    Am J Cardiol; 2016 Sep; 118(6):866-872. PubMed ID: 27453514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends over the past 4 years in population characteristics, 30-day outcomes and 1-year survival in patients treated with transcatheter aortic valve implantation.
    Avinée G; Durand E; Elhatimi S; Bauer F; Glinel B; Dacher JN; Cellier G; Viart G; Tron C; Godin M; Litzler PY; Cribier A; Eltchaninoff H
    Arch Cardiovasc Dis; 2016; 109(8-9):457-64. PubMed ID: 27342810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
    Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with safe early discharge after transcatheter aortic valve implantation.
    Aldalati O; Keshavarzi F; Kaura A; Byrne J; Eskandari M; Deshpande R; Monaghan M; Wendler O; Dworakowski R; MacCarthy P
    Cardiol J; 2018; 25(1):14-23. PubMed ID: 28714522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transapical aortic valve replacement is a safe option in patients with poor left ventricular ejection fraction: results from the Italian Transcatheter Balloon-Expandable Registry (ITER).
    D'Onofrio A; Salizzoni S; Filippini C; Agrifoglio M; Alfieri O; Chieffo A; Tarantini G; Gabbieri D; Savini C; Immè S; Ribichini F; Cugola D; Raviola E; Loi B; Pompei E; Cappai A; Cassese M; Luzi G; Aiello M; Santini F; Rinaldi M; Gerosa G
    Eur J Cardiothorac Surg; 2017 Nov; 52(5):874-880. PubMed ID: 28977359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-Implantation Balloon Aortic Valvuloplasty and Clinical Outcomes Following Transcatheter Aortic Valve Implantation: A Propensity Score Analysis of the UK Registry.
    Martin GP; Sperrin M; Bagur R; de Belder MA; Buchan I; Gunning M; Ludman PF; Mamas MA
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation.
    Costa G; Barbanti M; Picci A; Todaro D; La Spina K; Di Simone E; D'Arrigo P; Criscione E; Valvo R; Reddavid C; Deste W; Sgroi C; Tamburino C; Giuffrida A; Garretto V; Privitera G; Cannizzaro MT; Inserra C; Veroux P
    EuroIntervention; 2020 Aug; 16(6):e494-e501. PubMed ID: 32091404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve.
    Wendler O; Schymik G; Treede H; Baumgartner H; Dumonteil N; Ihlberg L; Neumann FJ; Tarantini G; Zamarano JL; Vahanian A
    Circulation; 2017 Mar; 135(12):1123-1132. PubMed ID: 28104716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transaortic transcatheter aortic valve implantation: Results of the Polish arm of the ROUTE registry.
    Jagielak D; Bramlage P; Pawlaczyk R; Brzeziński M; Fijałkowski M; Łaskawski G; Ciećwierz D; Rogowski J; Kozaryn R
    Cardiol J; 2015; 22(6):651-6. PubMed ID: 26202653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.
    Panchal HB; Ladia V; Amin P; Patel P; Veeranki SP; Albalbissi K; Paul T
    Am J Cardiol; 2014 Dec; 114(12):1882-90. PubMed ID: 25438917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
    Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
    Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
    Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
    J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.